{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:47:06Z","timestamp":1767847626026,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.110111","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T02:03:13Z","timestamp":1594778593000},"page":"110111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin"],"prefix":"10.1016","volume":"143","author":[{"given":"Negin","family":"Mozafari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soha","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Mehdi-Alamdarlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110111_b0005","doi-asserted-by":"crossref","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","author":"Liu","year":"2020","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.mehy.2020.110111_b0010","doi-asserted-by":"crossref","unstructured":"Jin Y, et al., Virology, Epidemiology, Pathogenesis, and Control of COVID-19. viruses, 2020. 12.","DOI":"10.3390\/v12040372"},{"key":"10.1016\/j.mehy.2020.110111_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID- 19: an emerging target of JAK2 inhibitor fedratinib","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.mehy.2020.110111_b0020","article-title":"Coronavirus infections and immune responses","author":"Li","year":"2020","journal-title":"Med Virol"},{"key":"10.1016\/j.mehy.2020.110111_b0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmicb.2014.00296","article-title":"Coronavirus infection, ER stress and apoptosis","volume":"5","author":"Fung","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mehy.2020.110111_b0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","author":"Sh","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.mehy.2020.110111_b0035","first-page":"1","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2014\u2014a review of immune changes in patients with viral pneumonia","volume":"just-accepted","author":"Lin","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"Supplement 1","key":"10.1016\/j.mehy.2020.110111_b0040","first-page":"S11","article-title":"2. Classification and diagnosis of diabetes","volume":"40","author":"Al Wattar","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mehy.2020.110111_b0045","first-page":"36","article-title":"Clinical presentation and diagnosis of diabetes","volume":"17","author":"Evans","year":"2015","journal-title":"Diabetes and Primary Care"},{"issue":"2","key":"10.1016\/j.mehy.2020.110111_b0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.mehy.2020.110111_b0055","doi-asserted-by":"crossref","unstructured":"Kim, B. and E.L. Feldman, Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Experimental & molecular medicine, 2015. 47(3): p. e149-e149.","DOI":"10.1038\/emm.2015.3"},{"issue":"1","key":"10.1016\/j.mehy.2020.110111_b0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"De Luca","year":"2008","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.mehy.2020.110111_b0065","first-page":"435","article-title":"Diabetes mellitus and inflammation","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr DiabRep"},{"issue":"9","key":"10.1016\/j.mehy.2020.110111_b0070","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.mehy.2020.110111_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab"},{"issue":"268","key":"10.1016\/j.mehy.2020.110111_b0080","doi-asserted-by":"crossref","first-page":"p. pe4-pe4","DOI":"10.1126\/stke.2682005pe4","article-title":"Ser\/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance","volume":"2005","author":"Zick","year":"2005","journal-title":"Sci. STKE"},{"issue":"44","key":"10.1016\/j.mehy.2020.110111_b0085","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mehy.2020.110111_b0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg. Microbes Infect"},{"key":"10.1016\/j.mehy.2020.110111_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","author":"Li","year":"2020","journal-title":"J Pharm Anal"},{"issue":"3","key":"10.1016\/j.mehy.2020.110111_b0100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12020-016-1073-8","article-title":"DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-\u03baB activation","volume":"55","author":"Hu","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.mehy.2020.110111_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.regpep.2014.09.006","article-title":"Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice","volume":"194","author":"\u00dajhelyi","year":"2014","journal-title":"Regul Pept"},{"issue":"23","key":"10.1016\/j.mehy.2020.110111_b0110","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2174\/092986709788803114","article-title":"Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme","volume":"16","author":"Matteucci","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.mehy.2020.110111_b0115","doi-asserted-by":"crossref","unstructured":"Sun Q, et al., DPP4 regulates the inflammatory response in a rat model of febrile seizures. Bio-Med Mater Eng., 2017. 28(s1): p. S139-S152.","DOI":"10.3233\/BME-171635"},{"issue":"9","key":"10.1016\/j.mehy.2020.110111_b0120","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2012-1544","article-title":"Sitagliptin exerts an antinflammatory action","volume":"97","author":"Makdissi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10229","key":"10.1016\/j.mehy.2020.110111_b0125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mehy.2020.110111_b0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tips.2009.08.003","article-title":"Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?","volume":"30","author":"Yazbeck","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"10223","key":"10.1016\/j.mehy.2020.110111_b0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.mehy.2020.110111_b0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2020.00105","article-title":"Inflammation as a modulator of host susceptibility to pulmonary influenza, pneumococcal, and co-infections","volume":"11","author":"Aguilera","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110111_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","author":"McGonaglea","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.mehy.2020.110111_b0150","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.mehy.2020.110111_b0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-kappaB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.mehy.2020.110111_b0160","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","article-title":"NF-kappaB signaling in macrophages: dynamics, crosstalk, and signal integration","volume":"10","author":"Dorrington","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110111_b0165","first-page":"8(6)","article-title":"Nanomodulation of Macrophages in Multiple Sclerosis","author":"Nally","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mehy.2020.110111_b0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12033","article-title":"NF-kappaB: roles and regulation in different CD4(+) T-cell subsets","volume":"252","author":"Oh","year":"2013","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.mehy.2020.110111_b0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2020.110111_b0180","doi-asserted-by":"crossref","unstructured":"Zhang B, et al., Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. 2020.","DOI":"10.1101\/2020.03.12.20035048"},{"key":"10.1016\/j.mehy.2020.110111_b0185","article-title":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev"},{"issue":"4","key":"10.1016\/j.mehy.2020.110111_b0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ajh.2009.1","article-title":"Markers of inflammation and hemodynamic measurements in obesity: Copenhagen City Heart Study","volume":"22","author":"Asferg","year":"2009","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.mehy.2020.110111_b0195","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.0901186","article-title":"Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development","volume":"183","author":"Alexaki","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.mehy.2020.110111_b0200","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm0809-846","article-title":"T-ing up inflammation in fat","volume":"15","author":"Lumeng","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2020.110111_b0205","doi-asserted-by":"crossref","unstructured":"Marette A. Molecular mechanisms of inflammation in obesity-linked insulin resistance. Int J Obesity, 2003. 27(3): p. S46-S48.","DOI":"10.1038\/sj.ijo.0802500"},{"issue":"2","key":"10.1016\/j.mehy.2020.110111_b0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imm.12394","article-title":"Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections","volume":"144","author":"Hodgson","year":"2015","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.mehy.2020.110111_b0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"issue":"5249","key":"10.1016\/j.mehy.2020.110111_b0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1-and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.mehy.2020.110111_b0225","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.110111_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.110111_b0235","unstructured":"Muniyappa R, Gubbi S. COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus. Am J Physiol-Endoc M. 0(0): p. null."},{"issue":"2","key":"10.1016\/j.mehy.2020.110111_b0240","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tube.2012.10.003","article-title":"Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control","volume":"93","author":"Gomez","year":"2013","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.mehy.2020.110111_b0245","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum Immunol"},{"issue":"7","key":"10.1016\/j.mehy.2020.110111_b0250","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/03639045.2018.1438460","article-title":"An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes","volume":"44","author":"Thondawada","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"10.1016\/j.mehy.2020.110111_b0255","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/app8060861","article-title":"An effective delivery system of sitagliptin using optimized mucoadhesive nanoparticles","volume":"8","author":"Haq Asif","year":"2018","journal-title":"Appl Sci"},{"issue":"2","key":"10.1016\/j.mehy.2020.110111_b0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2010.08.064","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes","volume":"213","author":"Ta","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2020.110111_b0265","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6091014","article-title":"Neuroprotective activity of sitagliptin via reduction of neuroinflammation beyond the incretin effect: Focus on Alzheimer\u2019s disease","volume":"2018","author":"Wici\u0144ski","year":"2018","journal-title":"Biomed Res Int"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:29:26Z","timestamp":1759692566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720313128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":53,"alternative-id":["S0306987720313128"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110111","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110111"}}